Atlas Trials

Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation

Clinical trial NCT00429416 · COMPLETED

Trial details

NCT number
NCT00429416
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hematologic Malignancies
Start date
2004-03-01
Primary completion
2008-12-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.